Based on the results obtained, we suggest that although the HLA-B*58:01 allele may be a predominant allele in patients with ALP-induced CARs, the correlation between the presence of the HLA-B*58:01 allele and the occurrence of MCARs in ALP-treated patients with gout is not as strong as that of SCARs. This evidence concerns the gene HLA-B and gout.